Avation Medical’s Kimberly Wilkinson was recognized by The Healthcare Technology Report in its recent announcement of The Top 25 Healthcare Tech Leaders of Houston, TX for 2022. As Senior Director of Clinical Operations, Kimberly leads Avation Medical’s clinical trial strategy to demonstrate the efficacy, safety, and ease of use of the Company’s game-changing digitally enabled wearable neuromodulation therapy and behavioral support platform to treat overactive bladder and urge urinary incontinence. With over 20 years of experience in the pharmaceutical and medical device industries, Kimberly has demonstrated a passion for ensuring that effective and safe medical technologies that can meaningfully improve care, are brought to market.
Please join us in celebrating Kimberly Wilkinson of Avation Medical, as one of the Top 25 Healthcare Technology Leaders of Houston for 2022.
About Avation Medical
Avation Medical is an innovative advanced neuromodulation and digital health company pioneering closed-loop, patient-friendly, wearable neuromodulation therapies that deliver personalized therapy based on the patient’s own physiologic response. The Company’s intelligent wearable therapies objectively confirm activation of the target nerve and make neuromodulation technology accessible to millions of patients across a variety of clinical applications by eliminating the need for surgery, needles and permanent implants and shifting therapy into the home environment.
The Company’s wearable bladder therapy and digital health system is available for investigational use only and is not FDA cleared.
Senior Director, Finance